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Microglia are the resident immune effector cells of the central nervous system (CNS)
rapidly reacting to various pathological stimuli to maintain CNS homeostasis. However,
microglial reactions in the CNS may also worsen neurological disorders. Hence, the
phenotypic analysis of microglia in healthy tissue may identify specific poised subsets
ultimately supporting or harming the neuronal network. This is all the more important for
the understanding of CNS disorders exhibiting regional-specific and cellular pathological
hallmarks, such as many neurodegenerative disorders, including Parkinson’s disease
(PD). In this context, we aimed to address the heterogeneity of microglial cells in
susceptible brain regions for PD, such as the nigrostriatal pathway. Here, we combined
single-cell RNA-sequencing with immunofluorescence analyses of the murine nigrostriatal
pathway, the most affected brain region in PD. We uncovered a microglia subset, mainly
present in the midbrain, displaying an intrinsic transcriptional immune alerted signature
sharing features of inflammation-induced microglia. Further, an in situ morphological
screening of inferred cellular diversity showed a decreased microglia complexity in
the midbrain when compared to striatum. Our study provides a resource for the
identification of specific microglia phenotypes within the nigrostriatal pathway, which
may be relevant in PD.
Keywords: microglia, nigrostriatal pathway, single-cell transcriptomics, cellular heterogeneity, immune alerted,
cell morphology, Parkinson’s diseaseorg March 2021 | Volume 12 | Article 6396131
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Microglia are the resident immune effectors of the brain that
arise from the yolk sac and colonize the brain early during
embryonic development (1). Under homeostatic conditions,
both during development and in the adult brain, microglia
play key roles shaping the neuronal network through synaptic
pruning and phagocytosis of apoptotic neurons (2–5). In
addition, microglia scan the adult brain and can rapidly react
to threatening conditions to mainly maintain the brain
homeostasis. In this context, improper immune responses,
such as weakened or exaggerated microglia reactions, can play
a critical role in the development and progression of neurological
diseases with an immunological component (6–8). Thus, specific
microglial poised subsets ultimately supporting or harming the
neuronal network may contribute to the development and
progression of CNS disorders exhibiting regional-specific and
cellular pathological hallmarks, such as many neurodegenerative
disorders, including Parkinson’s disease (PD).
PD is the second most common neurodegenerative disease of
aging and the most frequent movement disorder (9). The
presence of intracellular inclusions of misfolded alpha-
synuclein (a-syn) and the loss of dopaminergic neurons in the
substantia nigra pars compacta (SNc), a basal ganglia structure
located in the midbrain, characterize the brain of PD patients. In
the healthy brain, the dopaminergic neurons in the SNc mainly
support the basal ganglia circuit by supplying the striatum with
dopamine. Consequently, dopamine levels in the dorsal striatum
of PD patients are decreased, triggering the impairment of the
nigrostriatal pathway leading to various non-motor and classical
motor dysfunctions, including bradykinesia, tremor, posture
impairment or rigidity (10–12). Importantly, a-syn aggregation
and loss of dopaminergic neurons are associated with
neuroinflammation, which also constitutes a hallmark of PD
(13). However, the effective role of the neuroinflammatory
processes in PD is still unclear. For example, it has not yet
been elucidated if specific microglia subsets within the
nigrostriatal pathway may play a causative or a protective role
for the development and progression of PD (14–16).
In the recent years, microglia heterogeneity in the healthy
brain is emerging (17–19). Specifically, microglia diversity across
various brain regions has been described at the level of their
density, morphology and transcriptional programs (20–22).
Further, single-cell RNA-sequencing studies enabled to detect
microglia heterogeneity beyond region specificity, unraveling
specific microglia subsets within different brain regions (23).
Still, none of the previous studies has addressed the heterogeneity
of microglial cells in susceptible brain regions for PD, such as the
nigrostriatal pathway, at single-cell resolution.
Here, we conducted single-cell RNA-sequencing of the
midbrain and striatum in 6-month-old female mice and
identified specific microglia subsets characterized by different
immune programs. Among them, we detected a subset, mainly
composed by microglial cells isolated from the midbrain,
displaying an intrinsic immune alerted state sharing genes
characterizing microglia under inflammatory conditions (24).
Further, we combined single-cell RNA-sequencing analyses withFrontiers in Immunology | www.frontiersin.org 2morphological and protein screening of inferred cellular
diversity taking cortical microglia as a paradigm for the
homeostatic resting state and cerebellar microglia as cells
displaying an immune alerted state (21). In line with the
single-cell transcriptomics results and their typical resting
state, microglia from the cortex and striatum showed higher
ramification length and increased branching points compared to
microglia from the cerebellum and midbrain. Lastly, we found
heterogeneity of microglial cell density within midbrain sub-
regions, with the number of Iba1+ cells being higher in the
substantia nigra pars reticulata (SNr), similarly to cortex and
striatum, while being lower in the SNc and ventral tegmental area
(VTA), comparable to cerebellum.
Taken together, our results shed light on the complexity of
microglial cell diversity in the nigrostriatal pathway and establish
a resource for the identification of specific phenotypes, which
might be relevant for the development of PD.MATERIALS AND METHODS
Animals
C57BL/6J female mice were housed in individually ventilated
cages (IVC) in a conventional animal facility at the University of
Luxembourg in agreement to the EU Directive 2010/63/EU and
Commission recommendation 2007/526/EC. Mice were kept in
groups under a dark-light cycle with ad libitum access to water
and food. The animal work of the present study has been
conducted and reported in accordance with the ARRIVE
(Animal Research: Reporting of In Vivo Experiments)
guidelines to improve the design, analysis and reporting of
research using animals, maximizing information published and
minimizing unnecessary studies.
Microglia Isolation, RNA Extraction
and RT-PCR
Six-month-old C57BL/6J female mice were euthanized in deep
anesthesia (intraperitoneal injection of medetomidine 1 mg/kg
and ketamine 100 mg/kg) and perfused with PBS. Mouse brains
were manually dissected into cortex, cerebellum, midbrain and
striatum and tissue was dissociated with Adult Brain
Dissociation Kit (Miltenyi Biotec). Microglia were subsequently
isolated by magnetic separation. Briefly, a total of 1x107 cells was
incubated with 90 µl of MACS buffer and 10 µl of CD11b
microbeads antibody (Milteny Biotec) for 20 min at 4°C. Total
RNA was extracted from eluted microglial cells using NucleoSpin
RNA Plus XS (Macherey-Nagel) for samples containing less than
100.000 CD11b+ cells, whereas the kit innuPREP RNA Mini Kit
2.0 (Analytik Jena) was used for samples constituted by more
than 100.000 CD11b+ cells. We measured the RNA
concentration and quality by Nanodrop (Nanodrop
technologies) and we performed reverse transcription using the
ImProm-II reverse Transcription System (Promega) according
to manufacturer’s instructions. Reverse transcription was
performed at 25°C for 5 min, followed by 42°C for 60 min and
70°C for 15 min. For the RT-PCR conducted in 96-well plates,March 2021 | Volume 12 | Article 639613
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(Biorad) and 0.5 µl of 10 µM primers. A total volume of 20 µl was
added to a LigthCycler 480 Multiwell Plate 96 white (Roche) and
RT-PCR was performed in the LigthCycler 480 II (Roche) using
the following program: 95°C for 3 min, 40 cycles at 95°C for 3
sec, 60°C for 3 sec and 72°C for 3 sec. For the RT-PCR conducted
in 384-well plates, 1 µl of cDNA was mixed with 2.5 µl of SYBR
Green Mastermix (Applied Biosystems) with 1.25 µl of water and
0.125 µl of 10 µM primers. A total volume of 5 µl was added to a
MicroAmp Optical 384 well-reaction plate (Applied Biosystems)
and RT-PCR was performed in the QuantStudio Design &
Analysis software (Applied Biosystems) using the following
program: 95°C for 3 min, 40 cycles at 95°C for 3 sec, 60°C for
3 sec and 72°C for 3 sec. The primer sequences were as follows.
Gapdh forward: TGCGACTTCAACAGCAACTC, Gapdh
reverse: CTTGCTCAGTGTCCTTGCTG; Cx3cr1 forward:
CCTGCCCTTGCTTATCAT, Cx3cr1 reverse: GCCTTCTTGC
GATTCTTG; Fcrls forward: TTCTGGTCTTCGCTCCTGTC,
Fcrls reverse: ACCGCGTCTTGCATTCCTAA; P2ry12 forward:
GTGCAAGGGGTGGCATCTA , P 2 r y 1 2 r e v e r s e :
TGGAACTTGCAGACTGGCAT. The threshold cycle of each
gene was determined as PCR cycles at which an increase in
reporter fluorescence above a baseline signal was measured. The
difference in threshold cycles between the target gene and
reference gene Gapdh yielded the standardized expression level
(dCT). The expression level of each gene was calculated with the
formula 2-dCT. Data are represented as mean ± standard error of
the mean (SEM) from three independent experiments. All
statistical analyses were performed using GraphPad Prism
8.0 (GraphPad Software, Inc., San Diego, CA). The significance
was analyzed by a one-way ANOVA followed by a post-hoc
Tukey’s test. Differences between groups were considered as
significant when p values were less than 0.05 (* p<0.05, **
p< 0.01, *** p<0.005).
Single-Cell RNA-Sequencing
Tissue Dissection and Library Preparation
Six-month-old C57BL/6J female mice were euthanized in deep
anesthesia by intraperitoneal injection of medetomidine (1 mg/
kg) and ketamine (100 mg/kg) and perfused transcardially with
phosphate-buffered saline (PBS). We manually dissected and
isolated striatum and midbrain from mouse brains on ice. We
separately dissected those brain regions using Adult Brain
Dissociation Kit (Miltenyi Biotec). Cells were re-suspended in
0.5% BSA and the single cell RNA libraries were captured using
the Drop-seq method (24). The 3’end enriched cDNA libraries
were prepared by tagmentation reaction of 600 pg cDNA sample
library using the standard Nextera XT tagmentation kit
(Illumina). Reactions were performed according to the
manufacturer’s instructions. The PCR amplification cycling
program used was 95°C for 30 sec, and twelve cycles at 95°C
for 10 sec, 55°C for 30 sec and 72°C for 30 sec, followed by a final
extension step at 72°C for 5 min. Libraries were purified twice to
reduce primers and short DNA fragments with 0.6× and 1×
Agencourt AMPure XP beads (Beckman Coulter), respectively.
Lastly, purified libraries were eluted in 10 ml Molecular GradeFrontiers in Immunology | www.frontiersin.org 3Water. Quality and quantity of the tagmented cDNA library were
evaluated using Bioanalyzer High Sensitivity DNA Chip. The
average size of the tagmented libraries before sequencing was
between 400 and 700 bps.
Purified Drop-Seq cDNA libraries were pulled together and
sequenced using Illumina NextSeq 500 with the recommended
sequencing protocol except for 6 pM of custom primer
( G C C TG T C CGCGGAAGCAG TGG TA T CAACG
CAGAGTAC) applied for priming of read 1. Paired-end
sequencing was performed for the read 1 of 20 bases (covering
the random cell barcode 1–12 bases and the rest 13–20 bases of
random unique molecular identifier) and for read 2 of 60 bases of
the mRNAs. Raw reads were further de-multiplexed and
processed using the Drop-seq computational pipeline (24).
Single-Cell RNA-Sequencing Data Analysis, Reads
Filtering, Alignment and Mapping Quality
We adopted the Drop-seq method as previously described (24).
The identification of the low quality cells was done separately in
each data set. In order to select only the highest quality data, we
sorted the cells by the cumulative gene expression. A subset of
cells with the highest cumulative expression was considered for
the analysis (25). Additional to this filtering, we defined cells as
low-quality, based on three criteria for each cell. The number of
expressed genes is higher than 200 with 2 median-absolute-
deviations (MADs) above the median, the total number of counts
is 2 MADs above or below the median and the percentage of
counts to mitochondrial genes is 1.5 MADs above the median.
Cells failing at least two criteria were considered as low quality
cells and filtered out from further analysis. Similar to the cell
filtering, we filtered out the low abundant genes being expressed
in less than 5 cells in the data. Moreover, we excluded the
mitochondrial and ribosomal genes from the rest of the
analysis. The integration of the filtered matrices of the different
tissues was performed using Seurat v3.1 (26). The final gene
expression matrix, which we used for downstream analyses,
consisted of 1,337 cells and 15,446 genes. The filtered count
matrix was normalized for library size per cell, whereby the
expression level of each gene was divided by the cell’s total library
size, multiplying this by a scale factor (10,000 default), and
natural-log transformed the result, using log1p. Principal
component analysis (PCA) was computed using the 5000 most
variable genes on the aligned data. The clustering of data was
performed using Louvain clustering. The resolution of the clustering
was selected based on the best silhouette score of the different
resolutions (27). The clusters were identified using the graph-based
clustering algorithm implemented in Seurat. Then, differential
expression analysis was used to identify whether this clustering
segregated the expected cell types in the brain. A short list of
manually curated markers was used to infer the identity of the
different clusters. Cells assigned as “microglia” were re-projected in
two dimensions using again the 5,000 most variable genes of this
subset. Next, we performed differential expression analysis on the
clusters of these projected microglia populations. For this, we used
the function FindAllMarkers on the normalized counts using
MAST (28) as test with the total number of transcripts in eachMarch 2021 | Volume 12 | Article 639613
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Bonferroni correction to correct for multiple hypothesis testing
(Padj). From this differential gene expression analysis, one small
population was annotated as oligodendrocytes. This cluster was
filtered out for further analysis. A new PCA was performed using
the normalized count matrix of the remaining “purified microglia”
population. The new clusters were checked for difference in gene
expression levels. We performed differential expression analysis
using a generalized linear method with linear predictors adding as
covariate the total number of transcripts in each cell using
Monocle2 (29). The Benjamini-Hochberg correction was applied
to correct for multiple hypothesis testing (here q values were used as
more advanced adjusted p-values, which not only consider the
sample size, but also take into account an optimized FDR).
Flow Cytometry Analyses
Single-cell suspensions were obtained as previously described for
single-cell RNA-seq analyses. Cells were re-suspended in ice-cold
HBSS with 2% FBS and 10 mMHEPES (FACS buffer) and filtered
through a 70 µm nylon mesh (CellTrics). For multicolor
phenotyping, cells were blocked with Fc receptor binding
inhibitor (anti-mouse CD16/CD32 monoclonal antibody; 1:100;
eBioscience) for 15min at 4°C to reduce binding of non-specific Fc-
gamma receptors, and then stained with fluorochrome-conjugated
antibodies (anti-mouse CD45-FITC antibody; 1:1000; eBioscience;
anti-mouse CD11b-PERCP_Cy5.5; 1:20; eBioscience; anti-mouse
CD83-PE; 1:500; Biolegend; anti-mouse CD206-APC; 1:50;
Biolegend) for 30 min at 4°C in the dark. Unstained (control) and
stained cells were washed and re-suspended in 100 µL of FACS
buffer prior acquisition. Before acquisition, the performance of the
instrument was assessed using CS&T beads according to the
manufacturer’s instructions. Single-stain controls were prepared
withUltraCompeBeads (eBioscience) following themanufacturer’s
instructions and thus used to calculate the compensation matrix.
Hoechst (0.1 µg/ml, Bisbenzimide, 33342; Sigma) was added
for dead cell discrimination. Samples were run on FACSAria
I Iu SORP cytometer (Becton Dickinson) and flow
cytometry data were analyzed using FlowJo software (v. 10.6.1,
Becton Dickinson).
Immunohistochemistry Analyses
Brains were fixed in 4% PFA for 24h and kept in PBS with 0.1%
NaN3. They were cut with vibratome (VT1000S from Leica) into
50 µm sagittal free-floating sections and kept at -20°C in a
cryoprotective medium (1:1 v/v PBS/Ethylene Glycol, 10g.L-1
Polyvinyl Pyrrolidone). For immunohistochemistry, sections
were washed (PBS), permeabilized (PBS with 3% H2O2 and
1.5% Triton X-100) and blocked (PBS with 5% BSA). Sections
were then incubated overnight (PBS with 0.3% Triton X-100 and
2% BSA) with IBA1 (1:1000; Wako) and tyrosine hydroxylase
(TH; 1:1000; ab76442) antibodies. IBA1 was visualized using
donkey anti-rabbit IgG Molecular Probes Alexa Fluor 647, while
TH using goat anti-chicken IgG Molecular Probes Alexa Fluor
488 (Thermo Fisher). Sections were mounted on glass slides
using DAPI-Fluoromount-G (SouthernBiotech). Sections were
imaged at 20x using Zeiss Confocal LSM-710. For microglialFrontiers in Immunology | www.frontiersin.org 4morphological analyses, Z-stack pictures were taken and at least
12 cells per region in four mice were analyzed using IMARIS
software (Bitplane). Lastly, we used GraphPad Prism 8 software
for statistical analyses. For parametric groups (cell density and
process length), we applied one-way ANOVA with post-hoc
Tukey’s test. We analyzed non-parametric groups (number of
branching points and number of segments) by using Kruskal-
Wallis followed by post-hoc Dunn’s test.RESULTS
Single-Cell Transcriptomics Identifies
Cellular Diversity of the Midbrain
and Striatum
To analyze the cellular and molecular heterogeneity of the
nigrostriatal pathway at single-cell resolution, we manually
dissected the midbrain and striatum from five 6 month-old
C57Bl/6J female mice and used the microfluidic Drop-seq
method for single-cell transcriptomics analyses (30) (Figure
1A). Unsupervised-clustering and t-distributed stochastic
neighbor-embedding (t-SNE) projection represented single
cells separated into individual clusters. Among 1,337 cells
considered for subsequent analyses, 480 cells were from the
midbrain and 857 cells from the striatum (Figure 1B).
Differential expression analysis featuring 15,446 most variable
genes between the clusters (FDR<0.05) identified nine specific
groups. To gather the resultant identity of the clusters, we
analyzed the expression levels of the top genes in each cluster
(Table S1). We annotated them based on cell type-specific gene
markers (31, 32). Specifically, we identified four main clusters,
corresponding respectively to astrocytes (e.g. Gja1, Plpp3, Slc1a2,
Aqp4), microglia (e.g. P2ry12, Hexb, Cx3cr1, Siglech),
oligodendrocytes (e.g. Plp1, Mbp, Mobp, Trf) and endothelial
cells (e.g. Ly6c1, Cldn5, Pltp, Pecam1). Four smaller clusters were
represented by ependymal cells (e.g. Ccdc153, Tmem212,
Dynlrb2, Rsph4a), choroid plexus cells (Kcnj13, Flor1, Clic6, Kl)
mainly constituted by striatal cells, neurons/neural stem cells
(Meg3, Snhg11, Ndrg4, Snap25) and pericytes (e.g. Cald1, Vtn,
Notch3, Snap25). Lastly, we identified a hybrid cluster
represented by a mix of cell-types, including cells expressing
neuronal (Scn7a, Map2) or oligodendrocyte precursor cell
(C1ql1, Pdgfra) markers (Figure 1C; Figure S1). Next,
following the comprehensive characterization of the clusters
(Figure 1D), we verified that identities, markers, and
proportions of cell types matched previous single-cell droplet-
based sequencing data from mouse brain tissue (Figure 1E) (33),
indicating that our results were robust for analyses. Lastly, we
showed that cell type distribution was similar across midbrain
and striatum, confirming that both cell suspensions contained
the brain cell types described above (Figure 1F).
Overall, our single-cell approach enabled to identify in an
unbiased manner different cell types present in the nigrostriatal
pathway, allowing studying them separately and at single-
cell resolution.March 2021 | Volume 12 | Article 639613




FIGURE 1 | Single-cell transcriptomics identifies cellular diversity of the midbrain and striatum. (A) Schematic representation of the experimental approach. Tissue
dissected and dissociated from midbrain (in green) and striatum (in orange) of six months-old C57BL/6J mice (pool of 5 mice) analyzed by Drop-seq. (B) t-SNE
projection of 1,337 single cells included in the study showing 480 cells isolated from midbrain (in green) and 857 cells from striatum (in orange). (C) Bar plots of
representative cell type-specific markers across nine identified clusters: microglia (P2ry12), astrocytes (Gja1), oligodendrocytes (Plp1), endothelial cells (Ly6c1), hybrid
(Scn7a and C1ql1), ependymal cells (Ccdc153), choroid plexus cells (Kcnj13), neurons/neuronal stem cells (Meg3 and Snhg11) and pericytes (Cald1, Vtn, Notch3)
clusters. See Figure S1 and Table S1 for additional cell type-specific markers used for cluster annotation. (D) Annotated clusters in the t-SNE map showing nine
specific groups identified by differential expression analysis featuring 15,446 total genes (FDR<0.05): microglia (in blue), astrocytes (in red), oligodendrocytes
(in green), endothelial cells (in purple), hybrid (orange), ependymal cells (brown), choroid plexus cells (in pink), neurons/neuronal stem cells (in grey) and pericytes
(in pale brown). (E) Pie chart depicting the percentage of the identified cell types. (F) Bar plot showing proportion of cell types within midbrain (in green) and
striatum (in orange).Frontiers in Immunology | www.frontiersin.org March 2021 | Volume 12 | Article 6396135
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Segregate Into Specific Immune Subsets
As we were interested to elucidate the heterogeneity of microglial
cells, we selected the corresponding cluster for downstream
analyses. First, by testing the purity of the microglia-associated
cluster, we identified few cells expressing oligodendrocytic
markers, such as Mbp, Mag or Plp1, thus we discarded these
cells for subsequent analyses (Figure S2). Uniform Manifold
Approximation and Projection (UMAP) representation of 210
uncontaminated microglial cells, with 169 cells harvested from
the striatum and 41 cells from the midbrain, revealed four
different subsets, namely homeostatic, intermediate 1 and 2
and immune alerted (Figure 2A). They all contained striatal
microglial cells, with a higher proportion of cells in the
homeostatic and intermediate subsets, while microglia from the
midbrain mostly clustered to the immune alerted subset (Figure
2B). To detect transcriptional differences between the four subsets,
we first performed differential expression analysis and identified 78
genes (q value < 0.05) (Figure 2C; Table S2). Corresponding gene
ontology analysis using DAVID (34, 35) revealed biological
processes associated to “inflammatory response”, “cytokine-
mediated signaling pathway”, “antigen processing and
presentation” and “response to lipopolysaccharide” (Figure 2D).
In line with these terms, KEGG analysis revealed pathways
underlying microglia activation, such as TNF, MAPK, Toll-like
receptor and NFkB signaling pathways (Figure 2E; Table S3).
Indeed, among the differentially expressed genes, inflammatory
markers, such as Nfkbiz, Ccl4, Cd83, Adamts1, Il1b, Icam1, Fth1,
Casp4, Lyz1, Gpr84, Cd14, Socs3 were up-regulated in the immune
alerted subset (Figure 2F). We confirmed increased amounts of
CD83+ cells among CD11b+CD45int cells, representing microglia,
in the midbrain (7.58 ± 0.7%) compared to cortex (2.15 ± 1.1%) and
striatum (2.42 ± 0.4%) by flow cytometry analyses (Figure 2G;
Figure S3). Additionally, antigen presenting cell markers, including
H2-aa, H2-ab1 or Cd74 were specifically up-regulated in the
immune alerted subset (Figure 2H), while this subset expressed
lower levels of the microglia homeostatic genes, such as Hexb,
Cx3cr1, P2ry12, C1qa and Fcrls (Figure 2I). This is reminiscent of
the decrease of homeostatic genes in reactive microglia under
inflammatory conditions, suggesting that cells belonging to this
cluster display an immune alerted-like state. We considered the two
intermediate subsets as transitions between homeostatic and
immune alerted microglia (Figure 2A). To exclude that the
immune alerted subset could be, at least partially, constituted by
non-parenchymal macrophages that mediate immune responses at
brain boundaries, namely border-associated macrophages (BAMs),
we verified the expression levels of their recently described specific
markers (36–40). Except for Cd74 and H2-Ab1, which are known
genes to be also expressed by activated microglia (41), additional
specific BAM markers were not detected (e.g. Lyve1 and Ccr2) or
expressed by few cells not pertaining to the immune alerted cluster
(e.g.Mrc1) (Figure S3), thus indicating that the identified microglia
subsets were mainly constituted by microglial cells. Flow cytometry
analyses aimed at examining the expression of CD206 (encoded by
Mrc1) in CD11b+CD45+ cells (approximately 2-3%) did not detect
differences across the analyzed brain regions, hence showing thatFrontiers in Immunology | www.frontiersin.org 6the midbrain is not enriched with BAMs when compared to
striatum and cortex (Figure S3).
A recent study described microglia in the cerebellum to be
more immune vigilant than cortical microglia (21). Therefore, we
examined the expression of microglia homeostatic genes in
freshly isolated microglia from midbrain or striatum and
compared them with microglia harvested from cortex and
cerebellum. For this, we manually dissected the cortex,
cerebellum, striatum and midbrain from 6-month C57Bl/6J
mouse females and extracted RNA from MACS-isolated
CD11b+ cells. In agreement with previous observations (21),
microglia isolated from the cerebellum expressed lower levels of
the homeostatic genes (e.g. Cx3cr1, Fcrls, P2ry12) when
compared to the cortex. In line with the results obtained at
single-cell resolution, we detected a trend to a decrease of the
homeostatic genes in the midbrain compared to the striatum,
although these differences did not reach statistical significance
(Figure S3), probably due to the heterogeneity that we detected
within these brain regions at single-cell resolution.
Lastly, besides differences in their immune phenotype,
microglial cells in the immune alerted subset exhibited an up-
regulation of genes related to TGF-b signaling (Atf3, Egr1),
epigenetic functions (H3f3b, Chd4), proliferation (Btg2),
reactive oxygen species-mediated cell death (Gpx1), energy
production (Atp5a1) and autophagy-linked genes (Vps29)
(Table S2).
Taken together, our data suggests that microglial cells in the
striatum and midbrain display different immune phenotypes, with
the latter enriched by immune alerted microglia. Further, bulk
analyses strengthen the importance of single-cell transcriptomics
studies, which enabled to detect unprecedented transcriptional
microglia subsets across the nigrostriatal pathway.
Midbrain-Enriched Immune Alerted
Microglia Show Transcriptional Similarities
to Inflammation-Associated Microglia and
May Be Supported by Other CNS
Glial Cells
Next, to further characterize the immune transcriptional profile
of midbrain-enriched immune alerted microglia, we compared
its signature with microglia under acute systemic inflammatory
conditions gathering the corresponding dataset from our recent
study conducted at single-cell resolution using the Drop-seq
technology (24). Intriguingly, our previous gene ontology
analysis detected biological processes related to “response to
lipopolysaccharide”. In this context, the comparison of
midbrain-enriched immune alerted microglia signature with
microglia from lipopolysaccharide-injected mice identified 50%
(39 out of 78) of shared differential expressed genes (e.g. Nfkbia,
Cd74, Socs3 or Il1a) (Figure 3A). Among these genes, 72% (28
out of 39) were up- or down-regulated in both immune alerted
and inflammation-associated microglia populations. Specifically,
genes such as Cd14, Gpr84, Il1b and Fth1 were upregulated in
both populations, while Ccl4, Cd83, H2-ab1, Casp4 were
exclusively overexpressed in the immune alerted subset (Figure
3B). Further, genes like Cx3cr1, Hexb, Fcrls and P2ry12 wereMarch 2021 | Volume 12 | Article 639613






FIGURE 2 | Microglia within the nigrostriatal pathway segregate into specific immune subsets. (A) UMAP plot of the re-projected microglia cluster showing four
distinct subsets: homeostatic (in grey), intermediate 1 (in pale blue), intermediate 2 (in purple) and immune alerted (in pink). (B) UMAP representation showing 210
microglial cells, with 41 cells from the midbrain (in green) and 169 cells from striatum (in orange). (C) Heatmap showing clustering analysis of single cells, featuring 78
differential expressed genes across the four subsets (q value < 0.05). Color bar represents z-scores (from low z-score in blue to high z-score in red) (Table S2).
(D) Cytoscape network analysis of gene ontology terms identified by DAVID analysis (p value < 0.05, node cut off q value < 0.1) of the 78 differentially expressed
genes across microglia subsets (Table S3). (E) Top 17 KEGG pathways identified by DAVID resulting from 78 differentially expressed genes (Table S3). (F) Dot plot
representing the expression of inflammatory genes across the microglia subsets. Circle diameter denotes percent expression; color code indicates average
expression levels. (G) Percentage of CD83+ cells within the CD11b+CD45int population quantified by flow cytometry. Bars represent mean ± SEM (cortex in pale
green; striatum in orange; midbrain in green). Unpaired Student t test (n = 3) (*p < 0.05, **p < 0.01). (H–I) Dot plots representing (H) antigen presenting cell markers
and (I) homeostatic genes across the microglia subsets. Circle diameter denotes percent expression; color code indicates average expression levels.Frontiers in Immunology | www.frontiersin.org March 2021 | Volume 12 | Article 6396137
Uriarte Huarte et al. Microglia Diversity in Nigrostriatal Pathwaydownregulated in both microglia populations, whereas Hspa1a
was solely decreased in the midbrain-enriched microglia
population (Figure 3C).
In the CNS, the intense crosstalk of microglial cells with
neurons and the other glial cells, including astrocytes,
oligodendrocytes and ependymal cells, is critical for the
acquisition of the microglial phenotype. Hence, we sought to
analyze differentially expressed genes between midbrain and
striatum within the corresponding cell clusters (Table S4). The
low number of neurons isolated with our protocol did not enable
us to analyze their differentially expressed genes between the twoFrontiers in Immunology | www.frontiersin.org 8regions. In contrast, we detected differentially expressed genes
across the other glial cells, especially in astrocytes and ependymal
cells. When focusing on highly up-regulated genes (logFC > 1;
adj p value < 0.05), the expression levels of Vwa1, Xpr1, H2-T3
and Foxb1 in astrocytes were increased in the midbrain
compared to striatum. Interestingly, H2-T3 gene, coding for H-
2 class I histocompatibility antigen, has been shown to be up-
regulated in murine astrocytes under IFNg exposure (42). On a
side note, supporting the accuracy of our dissected brain regions,
high expression levels of the transcription factor Foxb1 (forkhead
box B1) in the midbrain are in line with its specific expression inA
B
C
FIGURE 3 | Midbrain-enriched immune alerted microglia show transcriptional similarities to inflammation-associated microglia. (A–C) Venn diagrams showing
the comparison between 78 differentially expressed genes across midbrain/striatum microglia subsets and 2,148 genes characterizing inflammation-associated
microglia (24).March 2021 | Volume 12 | Article 639613
Uriarte Huarte et al. Microglia Diversity in Nigrostriatal Pathwaydiencephalic brain regions, such as the substantia nigra (43). In
this perspective, the Ttr gene coding for transthyretin, a protein
that in the brain is mainly produced in the choroid plexus (44),
was overexpressed in all the main identified cell types of the
striatum (Table S4). In ependymal cells, the expression levels of
Car9, Fam81b, Atp5f1, Sparcl1, Cfap36 and Fos genes were up-
regulated in the midbrain. Of note, Atp5f1 gene encodes a
subunit of mitochondrial ATP synthase, the enzyme that
catalyzes the production of ATP. Microglia are able to sense
and catabolize extracellular ATP, which triggers the recruitment
of microglial protrusions and is converted into AMP and
adenosine (45).
Taken together, we show that midbrain-enriched immune
alerted microglia share transcriptional features of inflammatory
and reactive microglia. Transcriptional differences of other glial
cells may support the identified “immune alerted” phenotype of
microglia in the midbrain.Microglial Density and Morphology Across
Midbrain and Striatum Are Heterogeneous
Then, we studiedmicroglial cell density andmorphology across the
previously analyzed brain regions. Anatomically, two main
subregions, namely the caudoputamen (CP) and the nucleus
accumbens (NA), constitute the mouse striatum (Figure 4A),
whereas three subregions, the SNc, SNr and VTA, compose the
midbrain (Figure 4B). To linkmorphology to functionality, we also
includedcortex andcerebellum inour analyses sincemicroglia from
these two brain regions have been previously described to have
different immunological phenotypes (21). We used IBA1 antibody
to study microglia and tyrosine hydroxylase (TH) to localize the
different brain regions and subregions in the mouse tissue by
immunofluorescence analyses. We identified different patterns of
microglial cell density, with CP, NA and SNr subregions composed
by similar shapes than cortex, whereasmicroglia density in the SNc
andVTAwas closer to cerebellum.Notably,weobserved significant
differences between SNc and SNr, with the latter havingmore IBA1
+ cells than SNc (p value<0.005) (Figure 4C). Then, to address the
complexity of microglia morphology, we analyzed three different
parameters: total process length, number of branching points and
number of segments. We first confirmed that even though all
microglial cells in the mouse brain have a spindle-shaped-like
morphology, cells in the cortex are far more complex than
cerebellar cells. By applying this analysis to our regions of interest,
we observed that microglia morphology in the striatumwas similar
to the corresponding cells in the cortex, whereas the lowermicroglia
complexity detected in the cerebellum was similar to midbrain
(Figures 4D–G). We did not detect significant morphological
microglia sub-regional variation within midbrain and striatum
(Table S5).
Taken together, our results confirm the spatial heterogeneity
of microglia across different brain regions and further
demonstrate organizational and morphological diversities
between midbrain and striatum, thus supporting the
transcriptional signatures identified at single-cell resolution
suggesting that microglia functionality within these regions
may be heterogeneous.Frontiers in Immunology | www.frontiersin.org 9DISCUSSION
Neuroinflammation linked to chronic or abnormal microglia
activation is supposed to contribute to the loss of dopaminergic
neurons in PD (46–48). Microglia actively contribute to PD
pathology by reacting to a-syn (49). However, it is still not clear
if different microglial cell populations in the healthy brain might
be more prone to aberrant activation, which might consequently
induce and sustain neurodegeneration under threatening
conditions. To address this question, transcriptomic differences
of microglia across specific brain regions have been studied over
the last years (17, 50). For example, various bulk approaches
elucidated microglia features across cortex, cerebellum,
hippocampus or the basal ganglia (21, 22, 51). These studies
confirmed the diversity of microglia across these brain regions,
with microglia in the hippocampus and cerebellum displaying a
marked immune vigilant status when compared to cortex and
basal ganglia. However, bulk analyses are not suitable to identify
specific cellular subsets, since they merely represent the average
of specific cellular programs. To overcome this difficulty, single-
cell approaches aided to detect, for example, a higher microglia
heterogeneity during development (23, 52). In the adult brain,
heterogeneity has been primarily linked to specialized microglial
cells displaying different predisposition to be activated (23, 50,
52–55). Here, we applied the Drop-seq method (30) to elucidate
microglia heterogeneity within the nigrostriatal pathway, the
main affected path in PD. First, we took advantage of this
technique to decipher the cell taxonomy across midbrain and
striatum, revealing the identity of all the main brain cells in line
with other studies identifying similar cell types in the cortex,
hippocampus or striatum (32, 56, 57). Intriguingly, we detected
few cells originally included in the microglia cluster expressing
oligodendrocytic markers that we discarded for further analysis.
We are currently investigating the biological or technical
relevance of these detected cells.
When focusing on microglia heterogeneity in our studied
regions, we identified a special subset prevalently composed by
cells of the midbrain. The corresponding upregulated genes were
mainly related to immune and inflammatory response, thus
indicating that this subset display an “immune alerted”
phenotype. Notably, microglial activation and inflammation have
been reported to contribute to neurodegeneration in in vivomodels
of PD by directly affecting the dopaminergic neurons (47, 58). In
addition, midbrain-enriched immune alerted microglial cells were
enriched for toll-like receptor (TLR) signaling pathways, which
have been linked to neurodegeneration (59). Specifically, TLR4 is
involved in microglia activation linked to PD and the lack of Tlr4 in
a PD-likemodel ofMPTP resulted in a reducedmicroglia activation
and a decreased neurodegeneration (60). Further, it has been shown
that TLR4 is necessary for a-syn uptake by microglia and their
subsequent activation (61). We also identified enrichment
expression of antigen processing and presentation markers,
including MHC-II signaling pathway. MHC-II is upregulated by
microglia in post-mortem brains of PD patients (62) and in vitro
models have shown its relation between microglia activation and
further neurodegeneration (63), thus indicating that MHC-II may
be a mediator directly involved in PD pathogenesis.March 2021 | Volume 12 | Article 639613
Uriarte Huarte et al. Microglia Diversity in Nigrostriatal PathwayExperimentally, peripheral injection of lipopolysaccharide
(LPS) in the mouse has been related to neurodegeneration (64)
by contributing to the aggregation of different proteins such as a-
syn (65). In addition, the consecutive injection of LPS aggravate
the loss of dopaminergic neurons, which occurs via the
activation of the microglial complement-phagosome pathway
(47). Taken together, this might indicate that the immune alerted
phenotype, mainly displayed by midbrain microglia and few
striatal microglia, might turn detrimental in the long term orFrontiers in Immunology | www.frontiersin.org 10under specific cues, contributing to dopaminergic neuronal loss
triggering PD-like pathogenesis. For example, aged microglia
exhibit a primed state characterized by a hyper-reactive response
towards threatening conditions. As a consequence, primed
microglia release higher amounts of cytokines and chemokines
that could turn neurotoxic, thus contributing to disease
progression (66). Intriguingly, following LPS administration,
midbrain microglia show an immunosuppressive response when




FIGURE 4 | Microglial density and morphology across striatum and midbrain are heterogeneous. (A) Representation of different areas analyzed for microglia density
and morphology. TH was employed to identify the brain regions, while IBA1 was used to visualize microglia. Scale bar, 1500 µm (CP, caudoputamen; NA, nucleus
accumbens; CRB, cerebellum). (B) Tile pictures showing midbrain sub-regions in sagittal mouse brain. Scale bar, 200 µm (SNr, substantia nigra pars reticulata; SNc;
substantia nigra pars compacta; VTA, ventral tegmental area). (C) Quantification of microglial cell density in the different brain areas, cortex (in pale green), cerebellum
(in pink), striatum (in orange) and midbrain (in green). Bars represent the mean ± standard error of the mean (SEM) from four independent mice. One-way ANOVA
with post-hoc Tukey’s test was used for statistical test (*p < 0.05, **p < 0.01, ***p < 0.005). (D) 3D reconstruction of representative microglial cells across different
brain regions. Scale bar, 10 mm (CRB, cerebellum; CP caudoputamen; NA, nucleus accumbens; SNr, substantia nigra pars reticulata; SNc, substantia nigra pars
compacta; VTA, ventral tegmental area). (E-G) Quantification of microglial cell complexity across brain regions. Bars represent the mean ± standard error of the
mean (SEM) from twelve independent Iba1+ cells. One-way ANOVA with post-hoc Tukey’s test was used for statistical test for process total length, whereas
Kruskal-Wallis followed by post-hoc Dunn’s test was used as statistical test for number of branching points and number of segments (NS not significant, *p < 0.05,
**p < 0.01, ***p < 0.005) (Table S5). CTX, cortex; CRB, cerebellum; CP caudoputamen; NA, nucleus accumbens; SNr, substantia nigra pars reticulata; SNc,
substantia nigra pars compacta; VTA, ventral tegmental area.March 2021 | Volume 12 | Article 639613
Uriarte Huarte et al. Microglia Diversity in Nigrostriatal Pathwaycortex, striatum or hippocampus, indicating that microglia in the
midbrain display a dampened response towards an inflammatory
insult, hence presenting a tolerogenic and not a primed phenotype
(67). Further, the analysis of microglia phenotypes associated with
chronic inflammation in a TNF transgenic mouse model recently
revealed distinct signatures across different brain regions, including
the cortex, striatum, hippocampus, thalamus and cerebellum.More
specifically, microglial cells located within the cortex, striatum and
thalamuswere characterizedby theoverexpressionof inflammatory
genes, such as Cxcl13, Ccl2, C3 and C4b, thus suggesting a more
pronounced reactive state of microglia under persistent
inflammation in these specific regions when compared to
hippocampus and cerebellum (68). These results are in line with
ourobservations since ithas beenpreviously shown that, at baseline,
hippocampal and cerebellar microglia exist in a more immune-
vigilant state (21). Hence, the intrinsic immune-alerted phenotype
in the midbrain evidenced by our results as well as the previously
described immune-vigilant state in the hippocampus and
cerebellum seem to confer microglia the ability to react to an
inflammatory stimulus at a lesser extent compared to the
corresponding cells in other analyzed brain regions. In the
midbrain, whether this putative reduced response might be
detrimental for the underlying dopaminergic neuronal network
as, for example, threatening conditions cannot be efficiently
resolved, remains a matter of investigation. In addition, whether
midbrain microglia will similarly respond to a PD-like insult, such
as a-syn aggregation or neuronal loss, requires further analyses.
Concomitantly to transcriptional adaptations, morphological
changes of microglia also underlie their activated state. Briefly,
amoeboidmicrogliawith shorter or thicker ramifications are linked
to an activated state, whereas highly ramified phenotypes are
associated to classical homeostatic microglia (69–71). In this
context, microglia complexity has been described to vary
depending on the localization of the cells across specific brain
regions (72). Indeed, microglia from cortex, hippocampus and
striatum are more complex than microglia from cerebellum (54,
73). In addition, microglia density decreases during the rise of
dystrophic and degenerating cells in the aging mouse nigrostriatal
pathway (74). In these perspectives, the development of
computational and machine learning approaches recently enabled
the identification of 9 microglia subsets based on 62morphological
features in the murine hippocampus (75). To complement our
analyses, it will be critical to use these approaches to further
unraveling clusters of cells across the analyzed brain regions.
Lastly, the recently described heterogeneity of neuronal
populations in the nigrostriatal pathway supports our results on
microglia diversity in the corresponding brain region. For example,
seven subsets of dopaminergic neurons have been identified in the
mouse brain, which are also present in humans (76, 77). These
studies also highlight the importance of investigating cellular
heterogeneity in the murine nigrostriatal pathway, since this
region is mainly conserved across mouse and human species.
The combination of single-cell transcriptomics and in situ
morphological approaches to study microglia phenotypes across
the nigrostriatal pathway at baseline enabled us to detect a small
subset of cells, mainly constituted by microglia in the midbrain,Frontiers in Immunology | www.frontiersin.org 11displaying an immune alerted phenotype, which might have
implications in PD. Whether those immune alerted microglia are
sustained by specific cues in the midbrain environment, such as
mediators released by the highly active dopaminergic neuronal
network, or they are ontogenetically different compared to other
brain regions needs further investigations. Additional studies
elucidating microglia immune phenotypes in relevant PD mouse
models and patients, both in males and females, using single-cell
transcriptional and imaging approaches, such as imaging mass
cytometry, will be critical to understand how different subsets of
cells might be beneficial or detrimental during the development and
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Supplementary Figure 1 | Cellular taxonomy across midbrain and striatum.
(A) Heatmap showing clustering analysis featuring 15 most variable genes per
cluster (FDR < 0.05). Color bar represents z-scores (from low z-score in blue to high
z-score in red). (B) t-SNE representation of cell-type representative genes. Color
bar represents z-scores (high z-score in red).Frontiers in Immunology | www.frontiersin.org 12Supplementary Figure 2 | Enrichment of microglial cells across midbrain and
striatum. (A) Left panel: UMAP representation of microglial cells from the midbrain
(in green) and striatum (in orange); right panel: UMAP representation showing four
distinct subsets with few microglial cells (in purple) clustering independently.
(B) Heatmap showing the corresponding microglial cells expressing
oligodendrocytic markers (padj < 0.05).
Supplementary Figure 3 | Immune phenotypes across specific brain regions.
(A) Flow cytometry gating strategy. (i) Cells of interest were gated based on forward-
scatter area (FSC-A) and side-scatter area (SSC-A). (ii) Doublets were excluded based
on forward-scatter area (FSC-A) versus forward-scatter height (FSC-H). (iii) Hoechst
wasused todiscriminatedeadand livecells. (iv)CD45-FITCandCD11b-PERCP_cy5.5
antibodies were used to gate microglia. (v) CD83-PE antibody was used to quantify
CD83 expression. (vi) CD45-FITC and CD11b-PERCP_cy5.5 antibodies were used to
gate themyeloid compartment. (vii) CD206-APCantibodywas used to quantify CD206
expression. (B) t-SNEandUMAPplots showingMrc1 expression across cell types (left)
and microglia (right), respectively. Color bars represent z-scores (from low z-score in
grey to high z-score in red). (C)Percentage of CD206+ cells within the CD11b+CD45+
population quantified by flow cytometry. Bars represent mean ± SEM (cortex in pale
green; striatum in orange; midbrain in green). Unpaired Student t test (n = 3).
(D) Expression levels of microglia homeostatic genemarkers in microglia isolated from
cortex (in pale green), cerebellum (in pink), striatum (in orange) and midbrain (in green)
analyzed by qPCR.Gapdhwas used as housekeeping gene. Bars represent the
mean ± standard error of the mean (SEM) from three independent experiments.
One-way ANOVA followed by a post-hoc Tukey’s test was used to infer
statistical differences between groups (*p < 0.05).REFERENCES
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